The fund announced today that its Board of Trustees approved a 1-for-3 reverse stock split of its common shares.
The Board of Trustees and Aberdeen believe that increasing the Fund’s market price per share through the reverse stock split may broaden the range of potential investors, thereby potentially improving the Fund’s liquidity and reducing transaction costs associated with buying and selling shares in the secondary market.
As a result of the reverse stock split, every three shares of the Fund’s outstanding common shares will be converted into one common share. Neither the total value of shareholders’ investments in the Fund nor the total value of the Fund’s portfolio holdings will be affected due to the reverse stock split. After the reverse stock split, shareholders’ accounts will have proportionally fewer common shares but with a proportionally higher share price and a proportionally higher net asset value per share. Also, each shareholder will hold the same percentage of the Fund’s outstanding common shares as was held immediately prior to the reverse stock split. In connection with the reverse stock split, the Fund’s stable monthly distribution will be adjusted from $0.04 per share to $0.12 per share, beginning with the first distribution to be declared following the effective date of the reverse stock split. This adjustment to the Fund’s monthly distribution will result in no change in monthly cash flow to shareholders as a result of the reverse stock split.
The Fund anticipates completing this reverse stock split prior to the open of trading on the New York Stock Exchange (the “NYSE”) on February 9, 2026. Old CUSIP: 00302L108. New CUSIP: 00302L207.